<DOC>
	<DOCNO>NCT00882531</DOCNO>
	<brief_summary>A national , multicentre , prospective , randomised , double-blind , phase III study 2 parallel group isotretinoin versus placebo patient present papular-pustular rosacea resistant standard therapy . A non-balanced group ( 2 isotretinoin /1 placebo ) design select since , give nature study disease , few patient receive placebo active isotretinoin . Treatment duration patient : 4 month , monthly evaluation Follow-up 2 month 4 month patient responsive 4 month treatment .</brief_summary>
	<brief_title>Isotretinoin Papular-Pustular Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>Adult Patients present papularpustular rosacea ( characterise least 8 lesion ( papule and/or pustule ) resistant least 3 month last two year standard treatment comprise systemic antibiotic ( cyclins ) without topical therapy Full compliance twoweek washout period topical systemic treatment rosacea time selection For woman childbearing age , use minimum one `` effective '' contraceptive method least one month willingness continue use effective contraceptive method continuously throughout study duration least one month end treatment . Women childbearing age must provide consent pregnancy test start treatment , monthly throughout treatment 5 week end treatment . Negative pregnancy test result within last 3 day ( female subject childbearing age ) No laboratory abnormality standard test Social Security medical cover Provision write date informed consent take part study Patients already receive isotretinoin rosacea within last 12 month acne Patients present perioral dermatitis Patients present miliary lupoid Patients present cortisoneinduced rosacea Pregnant breastfeed woman Patients repeat habitual heavy physical activity Patients know hepatic impairment present cytolysis attest laboratory result Patients present hyperaemia Patient present hypervitaminosis A Patients history hypersensitivity isotretinoin Patients allergy soy oil Patients tetracycline Patients depression treat time selection Patients currently take part take part another study last 3 month prior inclusion present study Patients protect law ( guardianship trusteeship ) Patients unable comply study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>